CIN has the ability to drive the emergence of drug resistance in patients; for example, chromosome translocations within ABCB1 can lead to overexpression of the MDR1/p-glycoprotein drug efflux pump (Patch et al. 2015; Christie et al. 2019). This evidence concerns the gene ABCB1 and cervical squamous intraepithelial neoplasia.